645
Participants
Start Date
October 31, 2013
Primary Completion Date
December 31, 2015
Study Completion Date
February 29, 2016
Hepatitis A vaccine and tetanus vaccine
Hepatitis A and/or tetanus vaccination will be given to participants in all group on day 0. All monovalent active hepatitis A vaccinations and all vaccines containing tetanus toxoid available in Switzerland may be used in the study
University of Geneva, University Hospitals, Division of Rheumatology, Geneva
University of Geneva, University Hospitals, Service de Médecine Tropicale et Humanitaire, Geneva
University of Bern, Inselspital, Division of Infectious Diseases and Travel Medicine, Bern
University of Bern, Inselspital, Division of Rheumatology, Bern
University Hospital of Basel, Rheumatology Division, Basel
Swiss Tropical and Public Health Institute, Basel
Cantonal Hospital Aarau, Division of Rheumatology, Aarau
University of Zurich, Epidemiology, Biostatistics and Prevention Institute, Divison of Infectious Diseases, Zurich
University of Zurich, University Hopsital, Divison of Rheumatology, Zurich
Cantonal Hospital St. Gallen, Division of Rheumatology, Sankt Gallen
University of Basel
OTHER
Swiss Tropical & Public Health Institute
OTHER
University of Bern
OTHER
University Hospital, Geneva
OTHER
Cantonal Hospital of St. Gallen
OTHER
Cantonal Hospital of Aarau, Switzerland
OTHER
University of Zurich
OTHER